在临床诊所中,对患有慢性便秘的老年患者使用埃米格西巴特的疗效
Yuji Sakai1,2, Toshio Tsuyuguchi3, Junichiro Kumagai4
1Department of Gastroenterology, Sakai Clinic, Kimistu 299-1162, Japan.
埃洛比西巴特有效地改善了慢性便秘患者的肠道运动,包括老年人. 这项研究发现,年轻人群和老年人群之间的疗效或不良事件没有显著差异.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 已知Elobixibat可以改善慢性便秘的肠道运动.
- 在老年慢性便秘患者中,其疗效和安全性在临床环境中仍未得到充分研究.
研究的目的:
- 评估埃米格西巴特对老年慢性便秘患者肠道排便频率和便形式的影响.
- 为了比较老年人 (≥65岁) 和年轻人 (<65岁) 成人群体之间的这些影响.
主要方法:
- 一项临床研究涉及35名慢性便秘患者 (<65岁) 和45名慢性便秘患者 (≥65岁).
- 服用10毫克埃博基西巴特,在治疗前和治疗后一周评估肠道排便频率和布里斯托尔便形式量表 (BSFS) 评分.
主要成果:
- 在这两年龄组中,Elobixibat显著改善了肠道排便频率和BSFS得分.
- 在老年患者和年轻患者之间没有观察到治疗疗效或不良事件发生率的显著差异.
- 20%的患者出现了不良事件,年龄组的发病率相似.
结论:
- 埃洛比西巴特在改善慢性便秘患者的肠道排便状态方面表现出有效性.
- 这种药物对于老年患者来说似乎是安全的,与年轻人相比,其疗效和不良事件概况是可比的.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
